Emulsi Biotech’s innovative oat lipid solutions

Emulsi Biotech AB was funded by researchers at Lund University, as a spin-off company from research conducted within ScanOats on the exciting oat lipids. The company aims to revolutionize oral drug delivery by introducing novel lipid mixture systems made from natural vegetable oils. Key goals include establishing solvent-free manufacturing, conducting scale-up calculations, assessing economic viability, and exploring the system as an oral drug delivery platform. Their innovative NanoLIPID platform has the potential to protect drug substances, enable slow release, and significantly enhance the body’s absorption of medications. The novelty of this technique lays in the methodology used to create and enzymatically modify emulsions. Emulsions are defined as a mix of two liquids that are immiscible, such as oil and water, which are unstable by nature and eventually will separate. By using high force processing, and addition of stabilizers, stability of the emulsion will increase. The method developed by Emulsi Biotech AB uses mild mixing, and no additives, to create structures that commonly require energy demanding steps. The formation of these structures is unique and both the method as such, and the structures formed, which is possible thanks to the exceptional properties of the oat oil.